Yong-Chan Kim
Director/Board Member at BAUDAX BIO, INC.
Net worth: 32 $ as of 2024-05-30
Yong-Chan Kim active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BAUDAX BIO, INC. | Director/Board Member | 2023-07-02 | - |
| Independent Dir/Board Member | 2023-07-02 | - | |
TeraImmune, Inc.
 TeraImmune, Inc. BiotechnologyHealth Technology TeraImmune, Inc. engages in the development of customized cell therapies for autoimmune diseases using the patient’s own Treg cells. Its pipeline includes Hemophilia A, Multiple Sclerosis, and B cell lymphoma. The company was founded by Yong-Chan Kim and Ji-Hoon Park in 2016 and is headquartered in Gaithersburg, MD. | Director/Board Member | 2019-03-31 | - |
| Chief Executive Officer | 2019-03-31 | - | |
| Founder | 2015-12-31 | - |
Career history of Yong-Chan Kim
Training of Yong-Chan Kim
| Chungnam National University | Doctorate Degree |
Statistics
International
| United States | 3 |
| South Korea | 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BAUDAX BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
TeraImmune, Inc.
TeraImmune, Inc. BiotechnologyHealth Technology TeraImmune, Inc. engages in the development of customized cell therapies for autoimmune diseases using the patient’s own Treg cells. Its pipeline includes Hemophilia A, Multiple Sclerosis, and B cell lymphoma. The company was founded by Yong-Chan Kim and Ji-Hoon Park in 2016 and is headquartered in Gaithersburg, MD. | Health Technology |
- Stock Market
- Insiders
- Yong-Chan Kim
- Experience
